Literature DB >> 19476435

Interleukin 17 production among patients with American cutaneous leishmaniasis.

Olívia Bacellar1, Daniela Faria, Márcia Nascimento, Thiago M Cardoso, Kenneth J Gollob, Walderez O Dutra, Phillip Scott, Edgar M Carvalho.   

Abstract

Interleukin 17 (IL-17) plays a critical role in inflammation and autoimmunity. Very little is known about IL-17 in protozoa infection. Here, we show that lymphocytes obtained from patients with mucosal leishmaniasis and cutaneous leishmaniasis produce higher levels of IL-17 than do lymphocytes obtained from uninfected control subjects (P<.01). There was a tendency for tissue obtained from patients with mucosal leishmaniasis to contain a higher number of cells expressing IL-17, compared with tissue obtained from patients with cutaneous leishmaniasis, and there was a direct correlation between the number of cells expressing IL-17 and the presence of cellular inflammation at the lesion site (r2 = 0.86; P<.001) These data support the role of IL-17 in the pathogenesis of the inflammatory reaction in leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19476435      PMCID: PMC2732405          DOI: 10.1086/599380

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection.

Authors:  Michelle N Kelly; Jay K Kolls; Kyle Happel; Joseph D Schwartzman; Paul Schwarzenberger; Crescent Combe; Magali Moretto; Imtiaz A Khan
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 2.  Interleukin-17 as an effector molecule of innate and acquired immunity against infections.

Authors:  Goro Matsuzaki; Masayuki Umemura
Journal:  Microbiol Immunol       Date:  2007       Impact factor: 1.955

3.  Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis.

Authors:  Daniela R Faria; Kenneth J Gollob; José Barbosa; Albert Schriefer; Paulo R L Machado; Hélio Lessa; Lucas P Carvalho; Marco Aurélio Romano-Silva; Amélia R de Jesus; Edgar M Carvalho; Walderez O Dutra
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Authors:  Sudeepta Aggarwal; Nico Ghilardi; Ming-Hong Xie; Frederic J de Sauvage; Austin L Gurney
Journal:  J Biol Chem       Date:  2002-11-03       Impact factor: 5.157

5.  Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis.

Authors:  Lis R V Antonelli; Walderez O Dutra; Roque P Almeida; Olivia Bacellar; Edgar M Carvalho; Kenneth J Gollob
Journal:  Immunol Lett       Date:  2005-11-15       Impact factor: 3.685

6.  Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.

Authors:  R L Bottrel; W O Dutra; F A Martins; B Gontijo; E Carvalho; M Barral-Netto; A Barral; R P Almeida; W Mayrink; R Locksley; K J Gollob
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects.

Authors:  Tomomi Hashimoto; Kazuo Akiyama; Noriaki Kobayashi; Akio Mori
Journal:  Int Arch Allergy Immunol       Date:  2005-06-02       Impact factor: 2.749

Review 8.  Interleukin-17 family members and inflammation.

Authors:  Jay K Kolls; Anders Lindén
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

Review 9.  Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis.

Authors:  Albert Schriefer; Mary E Wilson; Edgar M Carvalho
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

Review 10.  Interleukin-17 family and IL-17 receptors.

Authors:  T A Moseley; D R Haudenschild; L Rose; A H Reddi
Journal:  Cytokine Growth Factor Rev       Date:  2003-04       Impact factor: 7.638

View more
  48 in total

1.  Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions.

Authors:  C de Oliveira Mendes-Aguiar; R Vieira-Gonçalves; L H Guimarães; M P de Oliveira-Neto; E M Carvalho; A M Da-Cruz
Journal:  Clin Exp Immunol       Date:  2016-06-06       Impact factor: 4.330

Review 2.  Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.

Authors:  Lynn Soong; Calvin A Henard; Peter C Melby
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

3.  Pro- and anti-inflammatory cytokines in children with malaria in Franceville, Gabon.

Authors:  Sandrine Lydie Oyegue-Liabagui; Aline Gaëlle Bouopda-Tuedom; Lady Charlène Kouna; Sydney Maghendji-Nzondo; Herman Nzoughe; Nina Tchitoula-Makaya; Irene Pegha-Moukandja; Jean-Bernard Lekana-Douki
Journal:  Am J Clin Exp Immunol       Date:  2017-02-15

4.  Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Authors:  Augusto M Carvalho; Luiz H Guimarães; Rúbia Costa; Maíra G Saldanha; Iana Prates; Lucas P Carvalho; Sérgio Arruda; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

5.  IL-17 and Regulatory Cytokines (IL-10 and IL-27) in L. braziliensis Infection.

Authors:  R Novoa; O Bacellar; M Nascimento; T M Cardoso; R Ramasawmy; W N Oliveira; A Schriefer; E M Carvalho
Journal:  Parasite Immunol       Date:  2011-02       Impact factor: 2.280

6.  Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells.

Authors:  J S Coelho dos Santos; C A S Menezes; F N A Villani; L M D Magalhães; J Scharfstein; K J Gollob; W O Dutra
Journal:  Clin Exp Immunol       Date:  2010-10-21       Impact factor: 4.330

Review 7.  CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly.

Authors:  Fernanda O Novais; Phillip Scott
Journal:  Semin Immunopathol       Date:  2015-03-24       Impact factor: 9.623

Review 8.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

Review 9.  Immunoregulation in human American leishmaniasis: balancing pathology and protection.

Authors:  K J Gollob; A G Viana; W O Dutra
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

Review 10.  Cutaneous leishmaniasis: immune responses in protection and pathogenesis.

Authors:  Phillip Scott; Fernanda O Novais
Journal:  Nat Rev Immunol       Date:  2016-07-18       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.